Clinical Trial Update: Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating nebulized milrinone in hospitalized patients with advanced heart failure and cardiomyopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure

Drugs mentioned

• Milrinone (milrinone)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Heart Failure, Cardiomyopathy | Phase 1 | Status: COMPLETED